Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De CvfiledCriticalAlparis Sa De Cv
Priority to MXPA02007641ApriorityCriticalpatent/MXPA02007641A/en
Publication of MXPA02007641ApublicationCriticalpatent/MXPA02007641A/en
The present invention refers to the use of the pharmaceutical composition of two active principles, which are fluconazole and tinidazole, completely compatible and the composition for the administration in the human body. This combination is useful to eradicate vulvo-cervico-vaginal mixed infections and presents synergy to obtain an ample action profile in the therapy of this type of infections.
MXPA02007641A2002-08-082002-08-08Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration.
MXPA02007641A
(en)
Methods of treating, preventing or controlling a myelodysplastic syndrome, and reducing or preventing an adverse effect associated with the administration of a second active ingredient to a patient suffering from a myelodysplastic syndrome, pharmaceutical composition, unit dosage form, and kit
Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction